by The global Veterinary Point Of Care Diagnostics market size is expected to be worth around US$ 5.69 billion by 2030, according to a new report by Vision Research Reports.
The global Veterinary Point Of Care Diagnostics market size was valued at US$ 2.15 billion in 2020 and is anticipated to grow at a CAGR of 12.3% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39084
Table of Contents
Veterinary Point Of Care Diagnostics Market Growth Factors
Technological advancements, strategic initiatives by key market players, rising pet population and humanization, the need to reduce antimicrobial resistance, and the expansion of service offerings by vet clinics are key factors driving the market. Heska, for instance, allocates its R&D budget for developing new Analyzer and Diagnostics Platforms, expanding the menu of analyzer platforms, upgrading the cycle to already installed platforms, and other in-house inventions. The market witnessed a slowdown in sales, reduced demand, and logistical challenges due to the COVID-19 pandemic. The uncertainty was exacerbated by the changing lockdown measures, guidelines on the movement of people and goods, remote work, and self-quarantine conditions.
Several key animal health companies also registered increased profits during 2020. This was owing to the deployment of various strategic initiatives such as diverting their resources to profitable segments to ensure business continuity, acquisitions, and the launch of new products. Heska, for instance, reported 97.4% of growth in its revenue during the first quarter of 2021. IDEXX Laboratories, Inc. reported a 12% increase in year-on-year revenue, driven by the Companion Animal Group (CAG) diagnostics segment, during 2020.
Veterinary Point Of Care Diagnostics Market Report Coverage
| Report Scope | Details |
| Market Size | US$ 5.69 billion by 2030 |
| Growth Rate | CAGR of 12.3% From 2021 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Animal Type, Product, Sample type, Testing category, Indication, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | IDEXX Laboratories; Zoetis; Virbac; Heska Corporation; Thermo Fisher Scientific, Inc.; Neogen Corporation; Mindray; Esaote SpA; FUJIFILM Corporation; Woodley Equipment Company Ltd. |
By Sample Type Analysis
The blood/plasma/serum segment held the largest revenue share of over 40.0% in 2020. According to the Kirkwood Animal Hospital in the U.S., regular blood tests are recommended as a key part of a companion animal’s overall wellness program.
The urine segment is expected to grow at the fastest rate over the forecast period. For instance, ACON Laboratories, Inc. offers CentriVet URS Reagent Strips for Urinalysis.
The reagent strips can be used for detecting 10 parameters, including bilirubin and urobilinogen for signs of liver disease, leukocytes and nitrites for urinary tract infections, and glucose and ketone for diabetes mellitus.
By Product Analysis
The consumables, reagents, and kits segment accounted for the largest share of more than 55.0% in 2020. This is owing to large product availability, subscription-based or repetitive payments sales model for reagents and consumables, and other initiatives by key companies.
The instruments and devices segment is projected to expand at the fastest rate of over 11.6% in the forecast period owing to growing product enhancements and demand for these products. Pentra C400 clinical chemistry analyzer by HORIBA, Ltd., based in Japan, for instance, can be used for routine to specific tests owing to its 55 on-board assays.
By Testing Category Analysis
Parasitology dominated the market with a revenue share of over 17.0% in 2020. The hematology segment is estimated to expand at the fastest CAGR of 12.0% over the forecast period.
Zoetis, for instance, launched Imagyst in 2020 to enable vets to make fast and accurate diagnoses at the point of care by automating the fecal examination to detect endoparasitic eggs, cysts, and oocysts.
By End-use Analysis
Veterinary hospitals and clinics held the largest revenue share of over 50.0% in 2020. This is attributed to a higher volume of patients received in these facilities, growing adoption of point of care devices by vet clinics, and wide diagnostic services offerings.
The home care settings segment is expected to register the highest growth rate of 12.9% from 2021 to 2030 due to the rising product launches in this category and pet expenditure.
By Animal Type Analysis
Companion animals dominated the market with a revenue share of over 60.0% in 2020. The livestock animals segment is projected to grow at the fastest rate over the forecast period.
This is attributed to the rising pet population, increasing expenditure, growing adoption of pet insurance, and the need to secure food sources by safeguarding the health of livestock animals.
Dogs and cats, for example, dominate the pet population in the U.S. as per the National Pet Owners Survey of 2019 to 2020 by the American Pet Products Association (APPA). Americans were estimated to have spent over USD 100 billion on pets in 2020.
By Indication Analysis
The infectious disease segment held the largest revenue share of about 40.0% in 2020. The general ailments segment is estimated to expand at the highest rate of 11.4% over the forecast period.
The key factors contributing to this growth include the growing prevalence of acute and chronic diseases in animals, the longer lifespan of pets, product advancements, and pet humanization.
Independent Vetcare Ltd.’s South Devon Veterinary Hospital in the U.K. offers a full range of diagnostic endoscopy services using flexible and rigid endoscopes as well as video endoscopes.
By Regional Analysis
North America held the largest revenue share of over 50.0% in 2020. The regional market growth can be attributed to the presence of key market players and advanced veterinary health care infrastructure in the U.S. and Canada.
North America held the largest revenue share of over 50.0% in 2020. The regional market growth can be attributed to the presence of key market players and advanced veterinary health care infrastructure in the U.S. and Canada.
Read also @ External Defibrillators Market Size Hit US$ 7.5 Billion by 2030
Major Key Players Covered in The Veterinary Point Of Care Diagnostics Market Report include
- IDEXX Laboratories
- Zoetis
- Virbac
- Heska Corporation
- Thermo Fisher Scientific, Inc.
- Neogen Corporation
- Mindray
- Esaote SpA
- FUJIFILM Corporation
- Woodley Equipment Company Ltd.
Veterinary Point Of Care Diagnostics Market Segmentation
- By Animal Type
- Companion Animals
- Dogs
- Cats
- Horses
- Others
- Livestock Animals
- Cattle
- Swine
- Poultry
- Others
- Companion Animals
- By Product
- Consumables, Reagents, & Kits
- Instruments & Devices
- By Sample Type
- Blood/Plasma/Serum
- Urine
- Fecal
- Others
- By Testing Category
- Hematology
- Diagnostic Imaging
- Bacteriology
- Virology
- Cytology
- Clinical Chemistry
- Parasitology
- Serology
- Others
- By Indication
- Infectious Disease
- General Ailments
- Others
- By End-use
- Veterinary Hospitals & Clinics
- Home Care Settings
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- Israel
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Veterinary Point Of Care Diagnostics Market, By Animal Type
7.1. Veterinary Point Of Care Diagnostics Market, by Animal Type, 2021-2030
7.1.1. Companion Animals
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Livestock Animals
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Veterinary Point Of Care Diagnostics Market, By Product
8.1. Veterinary Point Of Care Diagnostics Market, by Product, 2021-2030
8.1.1. Consumables, Reagents, & Kits
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Instruments & Devices
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Veterinary Point Of Care Diagnostics Market, By Sample Type
9.1. Veterinary Point Of Care Diagnostics Market, by Sample Type, 2021-2030
9.1.1. Blood/Plasma/Serum
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Urine
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Veterinary Point Of Care Diagnostics Market, By Testing Category
10.1. Veterinary Point Of Care Diagnostics Market, by Testing Category, 2021-2030
10.1.1. Hematology
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Diagnostic Imaging
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Bacteriology
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Virology
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Cytology
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Virology
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Clinical Chemistry
10.1.7.1. Market Revenue and Forecast (2017-2030)
10.1.8. Parasitology
10.1.8.1. Market Revenue and Forecast (2017-2030)
10.1.9. Serology
10.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Veterinary Point Of Care Diagnostics Market, By Indication
11.1. Veterinary Point Of Care Diagnostics Market, by Indication, 2021-2030
11.1.1. Infectious Disease
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. General Ailments
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Veterinary Point Of Care Diagnostics Market, By End-use
12.1. Veterinary Point Of Care Diagnostics Market, by End-use, 2021-2030
12.1.1. Veterinary Hospitals & Clinics
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Home Care Settings
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Veterinary Point Of Care Diagnostics Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.1.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.1.5. Market Revenue and Forecast, by Indication (2017-2030)
13.1.6. Market Revenue and Forecast, by End-use (2017-2030)
13.1.7. U.S.
13.1.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.1.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.1.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.1.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.1.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.1.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.1.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.1.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.7. UK
13.2.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.8. Germany
13.2.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.9. France
13.2.9.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.9.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.9.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.9.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.10. Rest of Europe
13.2.10.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.10.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.10.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.10.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.10.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.7. India
13.3.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.9. Japan
13.3.9.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.9.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.9.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.9.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.9.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.10. Rest of APAC
13.3.10.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.10.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.10.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.7. GCC
13.4.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.9. South Africa
13.4.9.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.9.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.9.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.9.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.9.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.10. Rest of MEA
13.4.10.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.10.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.10.6. Market Revenue and Forecast, by End-use (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.5.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.5.5. Market Revenue and Forecast, by Indication (2017-2030)
13.5.6. Market Revenue and Forecast, by End-use (2017-2030)
13.5.7. Brazil
13.5.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.5.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.5.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.5.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.5.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.5.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.5.8.6. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 14. Company Profiles
14.1. IDEXX Laboratories
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Zoetis
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Virbac
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Heska Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Thermo Fisher Scientific, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Neogen Corporation
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Mindray
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Esaote SpA
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. FUJIFILM Corporation
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Woodley Equipment Company Ltd.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39084
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
